Paper Details 
Original Abstract of the Article :
The development of refractory tumor cells limits therapeutic efficacy in cancer by activating mechanisms that promote cellular proliferation, migration, invasion, metastasis, and survival. Benzimidazole anthelmintics have broad-spectrum action to remove parasites both in human and veterinary medicin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458798/

データ提供:米国国立医学図書館(NLM)

Benzimidazole Anthelmintics: A New Frontier in Cancer Treatment

This study explores the potential of repurposing benzimidazole anthelmintics, commonly used to treat parasitic infections, for cancer treatment. The research delves into the diverse mechanisms by which these drugs exert their antitumor effects, including the disruption of microtubule polymerization and the induction of apoptosis.

Repurposing Drugs: A Promising Strategy

The study highlights the potential of repurposing existing drugs for new therapeutic applications. Benzimidazole anthelmintics have shown promising anticancer activities in both laboratory studies and clinical trials. These drugs offer a potential alternative or adjunct to conventional cancer therapies.

New Hope for Cancer Patients: Broader Treatment Options

The potential of benzimidazole anthelmintics to treat cancer is a significant development in the fight against this devastating disease. These drugs offer a broader spectrum of treatment options, potentially increasing the effectiveness of therapy and improving patient outcomes.

Dr.Camel's Conclusion

Just as a desert nomad repurposes materials found in the arid landscape, researchers are cleverly repurposing drugs to tackle new challenges. This study sheds light on the potential of benzimidazole anthelmintics as anticancer agents, offering a glimmer of hope for patients seeking new treatment options. This research highlights the need for continued exploration of repurposing drugs, expanding the horizons of therapeutic possibilities.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-08-01
Further Info :

Pubmed ID

32895616

DOI: Digital Object Identifier

PMC7458798

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.